Healthcare and Pharmaceutical Awards 2026 www.ghp-news.com Featuring:
Global Health & Pharma is proud to announce the Healthcare & Pharmaceutical Awards 2026 – a celebration of excellence across one of the world’s most vital and rapidly evolving sectors. Healthcare & Pharmaceuticals Awards 2026 From pioneering healthcare providers and innovative pharmaceutical companies to emerging medtech firms and research leaders, this prestigious awards programme honours those transforming patient care, driving medical innovation, and improving lives around the globe. Recognising Excellence in Global Healthcare Valued at over $10 trillion worldwide, the healthcare and pharmaceutical industry continues to expand in 2026 and beyond – powered by advances in biotechnology, personalised medicine, AI-driven healthcare, and digital therapeutics. As the world’s health systems evolve to meet complex challenges, innovation and collaboration are reshaping the delivery, accessibility, and effectiveness of care. The Healthcare & Pharmaceutical Awards 2026 shine a light on these visionaries redefining modern medicine – from life-changing treatments and diagnostic breakthroughs to patient-centred services and community health initiatives that raise the bar for excellence Sofi Parry, Senior Editor Website: ghpnews.digital AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.
Contents 4. Smiro Qualitas Limited: Best Independent Pharmaceutical Industry Consultancy 2026 – UK & GHP Client Satisfaction Excellence Award 2026 6. Caretree Ltd: Most Dedicated Live-In Care Provider 2026 - Oxfordshire 8. Samel Hospital: Leading AI Clinical Copilot Transforming Care Delivery 2026 – Brazil 10. Dalgety UK Ltd: Botanical Medicine Excellence Award 2026 11. SonnyHealth: Best Private Paediatric Diagnostic & General Health Clinician 2026 - Northern Ireland 12. Ravenall Institute: Best Holistic Healthcare Coaching Company 2025 - South Africa 13. Nazareth Care: Most Dedicated Assisted & Independent Living Organisation 2026 - Southern Africa 14. SteriCUBE®: Breakthrough Sterilization Technology of the Year 2026 – USA & Best Clinical Implementation Team 2026 – USA 15. Harley Street Hair Transplant Clinics: Best FUE & FUT Technical Hair Transplant Surgeon 2026 (North West): Abdelaziz Elgindi 16. Neural Consult by Dendritic Health, AI: Best AI-Powered Medical Learning Platform 2026 – USA 17. TMC Pharma Services Ltd: Rare Disease CRO of the Year 2026 18. Off Script Consults: Best Pharmacist Consultancy Service 2026 – USA 19. Intensity Therapeutics: Cancer Treatment Technology Innovator of the Year 2026 – USA 20. Epitomi Aesthetics: Most Trusted Medical Aesthetics Clinic 2026 – South East England & GHP Patient Care Excellence Award 2026 21. Gold Coast Physiotherapy: Best Emerging Physiotherapy Practice 2026 – Gold Coast & GHP Client Satisfaction Excellence Award 2026 22. Alora Medical (PTY) Ltd: Most Innovative MedTech Company 2026 – Southern Africa & Best Lung Clearing Device Brand 2026: RespiPEP 23. Dr Sunny Home Healthcare: Tech-Enabled Home Healthcare Innovators of the Year 2026 – UAE 24. HCA UK Medical Concierge Centre: Best Healthcare Concierge Service 2026 – UK 25. Seraphina Therapeutics (fatty15): Best Essential Fatty Acid Supplement Brand 2026 – USA & GHP Customer Satisfaction Excellence Award 2026
4 Jun23253 Pharmaceutical companies are currently navigating a landscape shaped by meticulous regulation, AI-powered transformation, and evolving market demands. Organisations are seeking a reliable partner to help them navigate such a landscape, and one independent pharmaceutical consultancy has risen to meet this demand head-on. Smiro Qualitas delivers expert clinical, commercial, and consulting services that aid clients in overcoming obstacles and seizing market opportunities whilst supporting their sustained business growth. We heard more from Director Robert Smith below, as we name Smiro Qualitas in the Healthcare and Pharmaceutical Awards 2026. ith sites based in the UK and Malta, Smiro Qualitas is a leading pharmaceutical company delivering end-to-end clinical services that keep programmes moving smoothly and compliantly across the UK and EU. The company focuses on highly specialised and innovative areas of the industry where deep technical knowledge and regulatory expertise are critical, including biologics, vaccines, biotechnology, radiopharmaceuticals, and advanced therapy medicinal products. In this field, Smiro Qualitas serves a wide range of clients, from small- to medium-sized pharmaceutical companies and NHS units to pharmaceutical wholesalers and other consultancies requiring specialist expertise not typically available in-house. It offers a comprehensive suite of services including batch review, batch certification and release, auditing, training, and Pharmaceutical Quality System (PQS) development and implementation. It also supports clients in obtaining key licences such as MIA, MIA(IMP), and WDA(H), alongside providing PQS remediation and broader strategic consultancy. Across its offerings, Smiro Qualitas operates with complete transparency; if the team believes that there is a more effective or cost-efficient method, it will advise its client accordingly. This approach is driven by a true understanding of each client’s unique needs, often challenging the initial brief to uncover the most appropriate solution. “In many cases, the outcome we deliver differs from what was originally requested,” said Robert, “but it is ultimately more effective, compliant, and commercially sound.” He continued: “We are deeply committed to patients, product quality, and customer outcomes and are not afraid to challenge or clients or present difficult truths when necessary. However, we always do so constructively, pairing insight with practical, deliverable solutions. This combination of expertise, flexibility, integrity, and hands-on problem-solving is what truly sets us apart.” In a dynamic market, Smiro Qualitas differentiates itself through its ability to combine technical excellence with quality and pragmatism. This is supported by a small, highly experienced team of experts, which allows it to remain agile, responsive, and closely connected to its clients whilst ensuring that every project benefits from deep specialist knowledge. Unlike larger organisations, where more rigid structures can limit flexibility, Smiro Qualitas develops fully customised proposals tailored to each client’s specific needs. The team does not take a one-size-fits-all approach to service delivery; its size and unrivalled expertise enables it to adapt quickly and design solutions that are both practical and proportionate. Smiro Qualitas’ pragmatic approach is essential in the fast-moving world of pharmaceuticals, especially as the industry continues to evolve at rapid pace. The industry is currently facing the widespread adoption of artificial intelligence, which presents both a significant opportunity and a complex challenge for the space. It has the potential to accelerate drug development, streamline batch record review, support QP decision-making, and enhance overall GMP compliance. At the same time, the effectiveness of artificial intelligence is entirely dependent on the quality and breadth of data used to train it. “Without this, its value is limited,” Robert stated. “There is also significant question around how AI systems will be validated within a regulated environment. To move forward confidently, Best Independent Pharmaceutical Industry Consultancy 2026 – UK & GHP Client Satisfaction Excellence Award 2026 W Smiro Qualitas Limited
GHP Healthcare and Pharmaceutical Awards 2026 the industry will require clear, practical regulatory guidance. Until then, organisations must approach adoption carefully, balancing innovation with compliance.” With such deep sectoral expertise and a strong understanding of its clients’ needs, Smiro Qualitas has positioned itself as a trusted partner capable of guiding organisations through this complex landscape. The company has solidified this position through obtaining its MIA, MIA(IMP), and WDA(H) licences, which have also provided the team with a strong foundation for scaling the business. Smiro Qualitas has further cemented itself as a key player in the pharmaceutical industry through the establishment of its site in Malta, allowing the company to provide a fully integrated service offering across both the UK and the EU. “This was a deliberate and strategic decision,” Robert told us. “We wanted to be pioneers. To our knowledge, our facility is the first of its kind in Malta, and we are proud to contribute to both the local clinical landscape and our clients’ ability to access the EU market.” Recently, Smiro Qualitas has supported a company entering the UK market in successfully securing its MIA and MDA(H) licences, which allow the client company to import, certify, release, and distribute its products in the market. To date, Smiro Qualitas has supported the success of 122 clinical studies, and lending its superlative services to 108 clients and driving the pharmaceutical industry forward. Smiro Qualitas was founded in 2012, beginning as a one-person venture established by experienced Pharmacist and Qualified Person Robert Smith. The company has since grown into an independent consultancy driven by a dedicated team of seven permanent professionals boasting more than 120 years of combined industry experience across all major sectors. Robert has led his team from strength to strength, raising Smiro Qualitas to stand as the UK’s Best Independent Pharmaceutical Industry Consultancy 2026. “For me, running Smiro Qualitas is not just a profession; it is a vocation,” he shared. “Since the age of 14, when I first understood how medicines can transform patients’ lives, this has been my driving passion. From my early career as a hospital pharmacist to becoming a Qualified Person in industry and now leading a group of companies, my focus has remained the same: ensuring patients have access to safe, effective, high-quality medicines. Everything we do at Smiro Qualitas ultimately comes back to that purpose.” As Smiro Qualitas continues to grow, a key priority for the team is maintaining and strengthening its customer focus. The company understands that what worked as a small organisation is not sustainable at scale, and is proactively evolving its structure to support both its clients and its people. It is currently undergoing a management restructuring to ensure clear accountability across operations, while allowing for greater strategic oversight at director level. It has also introduced a dedicated client liaison function to ensure seamless onboarding, maintaining the calibre of consistent delivery that has earned it the GHP Client Satisfaction Excellence Award 2026. 2026 is shaping up to be another strong year of growth and development for Smiro Qualitas, with new clients already onboarded and further opportunities in the pipeline. As the company explores expansion into additional healthcare services to broaden its offerings, we at Global Health & Pharma have no doubt that Smiro Qualitas will continue to lead the way in today’s pharmaceutical sphere. Contact: Robert Smith Company: Smiro Qualitas Web Address: www.smiroqualitas.co.uk
6 Caretree Ltd is an outstanding dedicated live-in homecare provider serving Oxfordshire and surrounding areas. Its expert team brings a compassionate and person-centred approach toward helping individuals live comfortably and independently in their own homes, underscored by being fully trained to support with a wide range of health conditions, including age-related needs, mobility challenges, and longterm complex and condition-specific requirements. Now recognised within the Healthcare and Pharmaceutical Awards 2026, we speak to Director, Jade Grigg to learn more about the care provider’s award-winning offering. “Our purpose is simple,” Jade begins. “To provide outstanding livein care that feels personal, compassionate, and truly supportive. We want every person we care for to feel safe, valued, and respected in the place they love most – their own home.” This is what lies at the foundation of what the Caretree team do. Offering specialist services in clinical-led domiciliary care and live-in care, Caretree was founded on the belief that every person deserves dignity, independence, and high-quality care. Its team work closely with each client, their family, and health professionals to get a full picture of their situation and to tailor their care plan to meet their individual needs and preferences for maximum independence and positive wellbeing. The excellent team of care professionals show their commitment and genuine care toward each client day in and day out. Jade tells us of the significant challenge to find truly great carers – people with heart, patience, and compassion – and when they do come, Caretree places great importance on retaining them. Caretree is very proud to be doing well at this, with very low turnover of staff. 40% of its carers have been with the company for four years or more, while 35% have been with it for two and a half years or more, and 25% for a year or more. Furthermore, 90% of the management team started as carers with Caretree before progressing into a senior position. “Our team isn’t just a workforce,” Jade says. “They are part of the Caretree family, and we make sure they feel recognised and appreciated for the outstanding work they do. We invest in our carers, celebrate their milestones and their strengths, and listen to their voices and reward them in the way they deserve.” The team feel valued and in turn, their devotion toward their daily work shines through. All homecare providers are regulated by the Care Quality Commission (CQC), with inspections held regularly, and Caretree has been identified as Outstanding in all five categories – Safe, Effective, Caring, Responsive, and Well Led. It is the first homecare provider in Oxfordshire to have received this. Caretree has undeniably raised the bar for care providers – and at the helm of it all is Jade Grigg, who brings extensive expertise in the field with more than seven years of experience within the domiciliary care sector and continuously proving herself as bestin-class across various areas of care delivery and management. “From making tea in your favourite cup, to plumping up your favourite cushions – now, that’s Caretree.” Further enhancing Caretree’s offering is its use of modern digital systems to stay responsive and connected, but as Jade emphasises, “It is our people who make the real difference.” She continues, “We take pride in recruiting, training, and retaining carers who share our values, with every member of our team being chosen not just for their skills, but for their kindness, empathy, and commitment to care delivery.” Not only does Caretree prioritise supporting the practical needs of those it works with, but also their overall wellbeing and quality of life. As part of this commitment, it has introduced a short weekly feature called “Thought of the Week”. Jade explains, “Each week, we share a brief reflection designed to encourage positive thinking, support wellbeing, and offer simple, practical insights that may be helpful in everyday life. These thoughts are shared with our stakeholders via email, and we have a dedicated section on our website where you will be able to view the latest “Thought of the Week”, as well as access previous reflections at any time.” So, what do the clients themselves have to say about their experience with Caretree? Shirley R. comments, “Fabulous company and excellent care for my 91-year-old mum. Caretree have been so supportive in every way. They are always on time, very kind and helpful, respectful, caring, and somehow always know what needs to be done to help my mum. The carers and office staff alike are so efficient and always contact me if there are concerns. I feel very lucky to have found them!” Caroline H. says, “My dad is cared for in his home by an amazing, wonderful live-in carer from Caretree. Both the agency and the carer are endlessly kind, supportive, and intuitive of both my father’s needs as well as mine. Dad is treated with dignity at all times, his needs are understood and met with homely personal contact, whilst professional standards and considerations remain paramount for both carer and all Caretree personnel. Contact between the carer and agency, with care notes shared with family via an app are invaluable and reassuring. Live-in care was a leap into the unknown, but we are gently led through with honesty and Most Dedicated Live-In Care Provider 2026 - Oxfordshire
GHP Healthcare and Pharmaceutical Awards 2026 openness. On behalf of all our family, we thank Caretree and Dad’s incredible carer. We are delighted to highly recommend.” Now, in terms of the future ahead, it is looking very bright indeed, as Jade reveals that it will be all about “continuing the work we are most proud of and strengthening what we already do well – providing outstanding live-in care and domiciliary care, supporting clients with a wide range of health needs, and ensuring our carers feel valued and supported in their roles.” If you would like to get in touch with Caretree, please submit the form here or call 01235 633300 to speak to a supportive member of staff. Contact Details Company name: Caretree Ltd Contact name: Jade Grigg Email: jade.grigg@caretree.co.uk Website: www.caretree.co.uk
8 Opening its doors in 1981, Samel Hospital has grown into one of the most respected and comprehensive healthcare institutions in Brazil’s North Region. Comprising three hospitals and six medical centres, with two additional hospitals currently under construction, Samel’s distinction lies in its multidisciplinary team of more than 1,500 employees and 900 physicians. Samel’s delivery of care is also aided by the SAMIA platform, for which it has received recognition in this programme. For more on Samel Hospital and its digital health innovation, we caught up with Zaira Nicolau. For 45 years, Samel Hospital has stood as a reference in healthcare across Brazil, with its seamless blending of tradition, innovation, and a genuine commitment to life having guided both the institution itself and its patients to a brighter, healthier present. The work Samel carries out revolves around 24/7 medical assistance delivered across multiple specialties and levels of complexity, with hospital services, emergency care, and diagnostic support being just some of the areas covered by the institution. There is an emphasis across all of these areas on improving patient outcomes, enhancing operational efficiency, and democratising access to advanced healthcare. As Zaira Nicolau told us: “Our focus is the integration of clinical excellence, technological innovation, and a strong people-centred culture to deliver high-quality, humanised care. We are particularly engaged in developing and implementing solutions that improve real-world care delivery.” Samel Hospital has a dedicated innovation environment where emerging technologies are transformed into tools that are useful, safe, and scalable, all within routine clinical practice. They can then be used to better serve the patients, clinicians, and healthcare teams across its diverse and dynamic care network. A great example of the high-calibre solutions this environment produces is SAMIA (Samel Artificial Intelligence), a platform integrated into Samel’s electronic health record and clinic workflows. Explaining this hospital artificial intelligence platform in more detail, Zaira Nicolau commented: “Acting as a clinical copilot, SAMIA supports healthcare professionals throughout the patient journey by assisting with digital pre-triage, structured history-taking, clinical documentation, diagnostic reasoning, exam recommendations, medication interaction alerts, and discharge guidance.” The recommendations it provides are sourced from a combination of the latest scientific evidence, international clinical guidelines, and institutional protocol. “Samel Hospital elevates clinical excellence and humanised care with SAMIA. Real-time AI support helps clinicians focus on patient-centred care, boosts productivity, and enables safer, standardised, evidence-based decisions across the care journey.” One of the defining features of SAMIA is its ability to deliver specialist AI agents, with these providing immediate, science-backed support to physicians during care delivery. The impact of this has been significant, with its implementation in Samel’s emergency department seeing time to first evaluation down by 34% and average length of stay in the department reduced by 24%. This is not all, as a 98% reliability rate was achieved across AI-generated histories, as well as an approximately 90% alignment with the physician’s final diagnosis. Lastly, as seen through SAMIA making medication interaction analysis 68% faster, both clinical efficiency and patient safety have seen demonstrable enhancements through the platform, which streamlines everything from electronic health record integration to clinical decision support. It therefore stands as a marker of digital health innovation in this space, and is something Samel is rightfully very proud of. Both SAMIA and Samel Health Tech more broadly benefit from the in-house development team Samel have in this area, as it these professionals who accelerate the creation and implementation of its digital health solutions. As Zaira Nicolau herself put it: “Through our in-house development team, we turn real frontline needs into scalable digital solutions.” AI may be aiding massively in this, but it is not replacing the institution’s fundamentals. For instance, Samel is, on an institutional level, guided by the core values of clinical excellence, integrity, innovation, humanised care, and accountability. Its overarching goal is to deliver high-quality healthcare, all whilst simultaneously improving outcomes, access, and efficiency through the responsible advancements it stands for concerning this technology development. Zaira Nicolau believes strict adherence to these values has a direct link with the high levels of satisfaction patients continue to report. “Our patients report high satisfaction throughout their care journey, while our technology helps make processes faster, more organized, and more secure.” Against this backdrop, Samel’s team have strongly embraced innovation and are actively contributing to the growth of the institution, focusing first and foremost on what makes it unique in Brazil’s healthcare landscape. This ultimately boils down to clinical excellence, humanised care, and practical innovation, all of which it offers within real-world healthcare environments. The value this brings is what makes it such a key sector player. Leading AI Clinical Copilot Transforming Care Delivery 2026 – Brazil
GHP Healthcare and Pharmaceutical Awards 2026 Zaira Nicolau captured the essence of Samel in her own words, telling us: “Our edge comes from implementing technology in ways that are not theoretical, but fully integrated into daily care delivery, improving efficiency, safety, and the patient experience.” This feeds into what she believes is the most significant breakthrough Samel has achieved: showing that innovation can be successfully embedded into real healthcare practices and used by medical professionals to offer improved patient experiences. As for what is next for the team here, Zaira Nicolau recognises that many healthcare technologies show promise, but few can be successfully integrated into real clinical and operational workflows. To ensure that the rate of adoption continues to increase, this director told us of Samel’s willingness to adapt by focusing on solutions that are practical, safe, and built around the real needs of medical professionals and their patients. The former also play an essential role in this process, as their feedback helps Samel improve its offerings. On the back of this, Zaira Nicolau continued: “Our focus is on continued growth in both infrastructure and innovation. We plan to further expand SAMIA across clinical and administrative areas, to continue improving efficiency, safety, and the patient experience.” As mentioned above, the construction of two new hospitals is currently being carried out, with this reflecting the long-term commitment these medical professionals have to expanding access to the gold standard of healthcare across Brazil’s North Region. Having pioneered in this landscape by adopting artificial intelligence through SAMIA, Samel Hospital has strengthened the patient experience, optimised administrative processes, reduced documentation burden for clinicians, and enabled more consistent, evidence-based care across the entire continuum in the Brazilian Amazon and beyond. As a result, we are delighted to recognise the institution with the title for Leading AI Clinical Copilot Transforming Care Delivery 2026 – Brazil within the pages of this programme. More on Samel Hospital can be found by visiting the web address listed below. Contact: Zaira Nicolau Company: Samel Hospital Web Address: https://www.samel.com.br/
10 GHP Healthcare and Pharmaceutical Awards 2026 Located in the Midlands, UK, Dalgety UK Ltd (Dalgety) is a cultivator of cannabisbased products for medicinal use (CBPMs), operating within a regulated clinical framework. It is the only cultivator in the UK to have achieved EU-GMP certification for the cultivation, manufacture, and supply of the cannabis flower as an active pharmaceutical ingredient (API). It does so while contributing toward the development of a reliable domestic supply chain within a rapidly evolving sector. At the same time, the company prioritises education, data, and the provision of clear, accurate information to support clinicians in navigating medical cannabis and making knowledgeable prescribing decisions. We speak to Chief Commercial Officer, Matt Clifton to learn more. Matt begins by telling us how one of the biggest challenges in the medical cannabis industry is perception versus reality. Medical cannabis is talked about in two extremes – either oversimplified or exaggerated – which makes it hard for patients and clinicians to gain a clear understanding. This is while the evidence continues to evolve, which makes handling it carefully and responsibly important. Meanwhile, there are also the practical challenges – Heavy reliance on imports and fragmented supply chains add complexity. As a UK-based cultivator, Dalgety aims to help build a more stable and transparent supply framework. “Dalgety was built with a clear intention,” Matt tells us. “To align cannabis cultivation with pharmaceutical standards from day one.” He continues, “Our values are centred on patient safety, scientific rigour, and long-term credibility. We believe that the future of medical cannabis depends on the industry holding itself to the same standards as other areas of medicine. That means prioritising consistency over novelty, evidence over assumption, and responsibility over shortterm commercial gain. These values shape how we operate day-today, from cultivation practices through to how we communicate as a business. In an industry that can at times be polarised, maintaining a measured and balanced approach has been critical to building trust with clinicians, regulators, and partners.” Dalgety’s facility has seen significant investment, with it being designed to allow for a high level of environmental control, consistency, and quality assurance. As a result of this commitment, the company has achieved EU-GMP certification for the cultivation of the cannabis flower as an API. Matt tells us that it is the company’s prioritisation of clinical credibility and operational excellence that has given it that leading edge – while others within the industry have leaned more toward branding or lifestyle promotion. As such, Dalgety’s focus extends beyond cultivation into data, consistency, and playing a responsible role in supporting prescribing decisions. “Medical cannabis should be viewed through the same lens as any other area of medicine. Progress in this space will come from data, consistency, and responsible practice, rather than broad claims or short-term trends. At Dalgety, we see our role as contributing to that progression, both through the products we produce and the standards we uphold.” Over the past year, the company has been scaling both its operational capability and its role within the UK market. It is actively progressing additional licencing so it can go beyond cultivation into a broader range of medical formats, including exploring opportunities across the supply chain, from processing through to the partnerships that support patient access. Additionally, it has invested in industry-wide education initiatives, including Medical Cannabis Awareness Month, to support greater understanding of CBPMs within a clinical context, as well as liaised the police, to keep them informed. This comes alongside an internal focus on refining its cultivation processes to ensure consistent, repeatable outputs, recognising that in a medical setting, reliability is just as important as innovation. Looking ahead, Dalgety will continue to focus on measured expansion, as Matt tells us, “2026 is a year of building on strong foundations, ensuring that as the market grows, we are positioned to scale in a way that remains consistent with our values and standards.” With all of that in mind, he concludes, “Medical cannabis should be viewed through the same lens as any other area of medicine. Progress in this space will come from data, consistency, and responsible practice, rather than broad claims or short-term trends. At Dalgety, we see our role as contributing to that progression, both through the products we produce and the standards we uphold.” Company name: Dalgety UK Ltd Contact name: Matt Clifton Email: matt.clifton@dalgetyuk.co.uk Website: www.dalgetyuk.co.uk Botanical Medicine Excellence Award 2026
11 GHP Healthcare and Pharmaceutical Awards 2026 onnyHealth is dedicated to providing comprehensive assessments for its patients across a wide range of acute multisystem pathologies and community presentations, with a particular focus on neurodivergence, anxiety, behavioural challenges, and complex cases where conventional approaches have not been effective. Diagnostic accuracy remains central at SonnyHealth, however it remains open to the fact that diagnosis alone may not always fulfil parental expectations and patient outcomes. “What differentiates SonnyHealth is its integrated model, combining high-quality medical diagnostics with targeted coaching support,” Dr Henderson explains. “This approach moves beyond standard pathways by working directly with young people to address the underlying drivers of confidence, behaviour, and engagement, rather than relying solely on parent-led strategies or clinical recommendations in isolation.” The clinic works with a diverse range of patients, including adolescents and young adults who have anxiety, reduced confidence, or behavioural challenges; individuals with neurodivergent profiles who require both diagnostic clarity and practical support; and families who are seeking a more effective approach after limited access to existing services. SonnyHealth’s services are available across numerous clinics across Northern Ireland, and it operates virtual clinics which have contributed to more efficient models of care delivery. Notably, this has informed wider system-level discussions on improving access to paediatric assessment and reducing wait times. At the core of everything SonnyHealth does are values of clinical excellence, accountability, innovation, and outcome-focused care. For SonnyHealth, excellence is non-negotiable – It assesses every child and young person according to the standards set by the Royal College of Paediatrics and Child Health, which ensures care covers the entire spectrum of acute and community paediatrics, as many presentations – particularly neurodivergence and behavioural health – do not fit neatly into single diagnostic categories. Accountability for outcomes is equally important – It goes beyond diagnosis, with success measured by whether the young person is experiencing improvement in their day-to-day functioning, confidence, and quality of life. Alongside this, innovation is certainly necessary. By combining medical diagnostics and targeted coaching support, the clinic can support individuals who have not seen progress through conventional routes, including those who have already engaged with standard therapies without meaningful change. “The specific focus of SonnyHealth is clear: to deliver clinically vigorous, whole-spectrum paediatric care while redefining success SonnyHealth is a specialist provider of paediatric diagnostic and health services, its aim being to address the growing gap between traditional medical assessment and realworld outcomes for children and young people from birth to the age of 16 years. Led by consultant paediatrician Dr Jonathan Henderson, we speak to him to learn more about the work of the award-winning SonnyHealth. Best Private Paediatric Diagnostic & General Health Clinician 2026 - Northern Ireland through outcomes – ensuring that children and young people not only receive accurate diagnoses, but develop the ability to function and adapt to everyday life.” These values directly influence the clinic’s success within the industry. Its consistent focus on achieving outcomes has led to strong word-ofmouth referrals from families, which has boosted engagement from insurers seeking more effective care pathways, and recognition from wider healthcare systems looking for more efficient service models. “In a landscape where demand is rising and traditional pathways are under strain, a values-driven approach that prioritises clarity, integration, and measurable results is not only differentiating – it is increasingly necessary,” says Dr Henderson. He continues, “The overarching goal is to redefine how paediatric care is delivered and measured, both at an individual and system level. This includes delivering timely, high-quality assessments that reduce delays in care; providing integrated support that translates into realworld improvement; and contributing to scalable models of care that can help address wider system pressures, including waiting lists.” Ultimately, it isn’t just one element that makes SonnyHealth unique; it’s the way clinical breadth, integration, and outcome accountability are all combined into a single model of care. In practical terms, it does not stop at identifying the problem – It is committed to resolving it in a way that is measurable, transferable, and sustainable in everyday life. Looking ahead, SonnyHealth plans to continue building on its current success, with the remainder of 2026 being for scaling impact while shifting further upstream towards reducing the need for late-stage intervention altogether. Royal College of Paediatrics and Child Health has reported on the consequences of delayed access to care, particularly in the context of child poverty and health inequality. By the time many children reach specialist service, difficulties are often deeply engrained and therefore harder to reverse. SonnyHealth is responding by actively developing a preventative, more accessible model of care, focusing on earlier engagement in primary school settings. Dr Henderson concludes, “Overall, the direction for 2026 reflects a deliberate evolution – from a service that responds effectively to need, to one that increasingly works to reduce that need through early intervention, education, and preventative paediatric care embedded within the community.” Company name: SonnyHealth Contact name: Dr Jonathan Henderson Email: info@sonnyhealth.com Website: www.sonnyhealth.com S
12 GHP Healthcare and Pharmaceutical Awards 2026 Unlocking the source code of the human operating system Dr Suzanne Ravenall and the eponymous Ravenall Institute represent a new paradigm on the human development scale and are spurring on a human performance revolution in the healthcare industry. A group of companies specialising in the transformations of individuals and businesses alike, the Ravenall Institute comprises a portfolio of leading brands, all operating atop an overarching vision to empower clients to take a leap, grow, and become the most successful versions of themselves. Dr Suzanne Ravenall and the Ravenall Institute Are Shaping the Future of Human Transformation In a world where burnout, fragmentation, and outdated systems continue to hinder human potential, Dr Suzanne Ravenall and the Ravenall Institute have emerged as global forces of transformation. Recognised for the fourth year in a row in the Healthcare and Pharmaceutical Awards, this time as Best Holistic Healthcare Coaching Company 2025 – South Africa, the group is revolutionising the intersection between healthcare, human potential, and performance with a deeply integrative, science-backed, and soulanchored approach. At the core of this revolution is Dr Suzanne Ravenall, a visionary leader, transformation & human pattern architect. With over 30 years of experience across corporate strategy, entrepreneurship, human behaviour, performance, and neuro-repatterning. She has pioneered a multi-brand ecosystem designed to identify, decode and rewire the patterns that break people, businesses, and systems — and rebuild them for radical thriving. An Ecosystem of Transformation The Ravenall Institute is not a single solution. It is an interconnected suite of brands that together form a blueprint for unleashing human potential at every level — individual, team, organisational, and societal. These brands include: • Dr Suzanne Ravenall Transformation – Coaching & neurorepatterning, for individuals ready to transcend old paradigms. • Repatterning.com – A global training platform certifying coaches in the proprietary patterning methodology. • The Human Performance Replicator™ – A corporate performance engine that models the top 10% of performers and builds systems to replicate their excellence across entire organisations. • The Effectiveness Company – A results-focused business execution consultancy and outsourcing firm that turns strategy into scalable success. • NCCBM (National Centre for Complementary and Behavioural Medicine) – A hub for science-informed energy psychology, epigenetics, and trauma-informed care. • Mediato International Alternative Dispute Resolution – Transforming conflict into clarity through a consciousnessbased mediation model. Each business is autonomous yet synergistic, guided by the Institute’s north star: to decode the subconscious patterns that sabotage progress and unlock the blueprint for peak performance and self-realisation. The Woman Behind the Vision Dr Ravenall is no ordinary leader. She is the embodiment of the very transformation she teaches. With a PhD, 20+ certifications, over 30 awards, and more than 10 million lives touched through company training, coaching, and keynotes, she bridges neuroscience, bioenergetics, corporate strategy, and ancient wisdom — offering not just improvement, but metamorphosis. Having spent over two decades in the upper echelons of corporate leadership, Suzanne guides others through radical inner rewiring that transforms not only how they perform — but who they become. “We can’t always predict the future, but we can shape it — powerfully and consciously,” says Dr Ravenall. “We are here to unlock patterns, energise performance, and raise the standard of what it means to be human.” The Holistic Future of Healthcare and Human Potential The Ravenall Institute operates at the convergence of science, soul, and strategy. Whether working with executives navigating burnout, individuals trapped in trauma loops, or companies stuck in performance bottlenecks, Suzanne and her team use a multilayered approach — combining applied neuroscience, behavioural repatterning, and systems thinking. This holistic methodology is what earned them the Healthcare Coaching Company of the Year 2020, 2021, 2023 2024 — and now, Best Holistic Healthcare Coaching Company 2025. Their work is not just healing. It is upgrading human capacity in real-time. From executive coaching and bioenergetics, to performance mapping, organizational design, and conscious business consulting, every touchpoint within the Ravenall ecosystem is designed to recode limitations into liberation. Best Holistic Healthcare Coaching Company 2025 - South Africa A Legacy of Impact
13 GHP Healthcare and Pharmaceutical Awards 2026 t Nazareth Care, aging is not seen as a stage of decline, but as a chapter of life that should be lived with dignity, purpose, and joy. This philosophy sits at the heart of the organisation’s recent recognition for Best Effort in Independent Living and Assisted Living, an award that celebrates not just innovation, but a deeply human approach to care, led by Chief Executive Officer; Henco Walker. Across the African Region, Nazareth Care has been quietly transforming what it means to grow older in a supportive environment. Where once care facilities were often perceived as clinical and institutional, Nazareth Care has reimagined its spaces into warm, homely, and active communities, places where residents feel a sense of belonging, independence, and connection. Walking into one of their renovated homes, such as Nazareth House Cape Town or Nazareth House Pretoria, you don’t encounter a traditional care facility. Instead, you find vibrant spaces filled with life, residents sharing meals, engaging in activities, and moving freely through environments designed to feel like home. A key part of this transformation has been the introduction of Wellness Coordinators, who take the time to truly know each resident, their interests, their stories, and what brings them joy. Activities are no longer generic; they are personalised, meaningful, and engaging, encouraging residents to participate, connect, and remain active members of a thriving community. Even something as simple as a meal has been reimagined. Dining at Nazareth Care is no longer a routine, it is an experience. Residents are welcomed into beautifully revamped dining spaces, with buffet options, live cooking, and themed events that bring variety and Most Dedicated Assisted & Independent Living Organisation 2026 - Southern Africa excitement to everyday life. The presence of chefs preparing meals on the floor transforms dining into a shared, social moment Every detail has been thoughtfully considered. Hair salons, lounges, libraries, and coffee shops have been transformed into themed spaces, creating moments that feel like outings rather than routines, purposefully designed to enrich daily living. Behind these changes lies a significant investment in both infrastructure and vision. Nazareth Care has introduced over 30 new rooms across its properties and renovated more than 60 independent and assisted living units, expanding its ability to serve more residents while elevating the standard of care. Yet, what truly sets Nazareth Care apart is not just what has been built, but why it has been built. At its core, the organisation remains deeply committed to its mission: to care for older persons with compassion and respect, while enabling them to live as fully and independently as possible. Chief Executive Officer; Henco Walker, says; “Looking ahead, this journey is far from complete.” Plans are underway to further enhance care through upgrades to frail care facilities with modern equipment and mobility aids, the introduction of electronic nursing systems to improve care planning, and continued investment in environments and services that enhance residents’ quality of life. For Nazareth Care, this award is not simply recognition, it is a reflection of a broader movement within the organisation to change the narrative around aging. At Nazareth Care, growing older doesn’t mean stepping back from life, it means continuing to live it, fully, in a place that feels like home. A
14 GHP Healthcare and Pharmaceutical Awards 2026 urgical Blue Wrap Delays Surgical instruments are brought to surgery in trays that are traditionally enveloped in blue wrap, a disposable polypropylene fabric that allows sterilants such as steam or ethylene oxide to penetrate and sterilize instruments. Though surgical blue wrap is predominantly used in hospitals around the world, the material has proven itself to be a time-consuming, wasteful, and even an outdated addition to the operating room. Whether wrapping before sterilization or unwrapping in the operating room, surgical blue wrap is known across medical settings for its lengthy preparation process. The material can also cause extensive operative delays when ripped, which accounts for 12% of its uses. Whilst surgeries are generally only delayed when blue wrap rips, there have also been incidents of surgeries being cancelled or delayed to a point of unnecessary overnight stays at the hospital. Based in Grapevine, Texas, SteriCUBE is on a mission to reshape the world of medical sterilization, working closely with hospitals and surgery centres to improve the safety and efficiency of the surgical instrument sterilization process. The company has produced the SteriCUBE, a large metal container that can hold all surgical trays to be quickly sterilized and rolled into the operating room. How SteriCUBE Sterilization Cabinets Work SteriCUBE sterilization cabinets are specifically designed to bring efficiency to the operating room. Rather than individual processing, this innovative product enables a single employee to quickly unload surgery-ready instruments and expedite operating room turnover. Not only does this save hours of time, but it also eliminates room for error and mitigates the likelihood of delayed or cancelled surgeries. S SteriCUBE® is a rigid metal sterilization cabinet that allows surgical instruments to be sterilized together and then delivered to the operating room without the delays associated with blue wrap. For decades, surgical blue wrap has been used to cover surgical instruments and maintain their sterility. This fabric is a staple of the operating room, but drastically reduces efficiency because the wrap is prone to ripping and must be carefully handled and unwrapped. Surgical facilities are seeking technologies to help them gain operational efficiency as the industry continues to advance. Today, we celebrate SteriCUBE, an emerging medical device company seeking to revolutionize sterilization efficiency across hospitals and surgery centres. Best-in-Class Support The company’s support extends far beyond the operating room, a common mistake medical device companies make is poor customer education as well as a lack of support provided once products have been implemented within the client’s facility. In a competitive market, SteriCUBE differentiates itself through bestin-class education and support, even going one step further to develop expert implementation teams that have been named the USA’s Best Clinical Implementation Team 2026. “One of our primary goals is to ensure our implementation teams meet with all stakeholders in a new facility and educate them on the value our product brings,” Senior Marketing Director Cara Bethell told us. “The team also works with the facilities to improve their processes for both efficiency and patient safety. Our company is having the kind of fast growth other companies pretend they have; this is obviously due to our product benefits, but also our devotion to helping facilities use our product for maximum effect.” This is an essential offering in today’s medical landscape, where SteriCUBE has observed a ubiquitous issue within healthcare facilities involving how their sterile processing departments are treated. These departments are commonly understaffed and overworked, as well as routinely blamed for issues that arise from other departments. Such challenges can make new product adoption a threatening process for sterile processing departments. They frequently exist within a blame culture that can threaten their job security or career advancement if a new product negatively impacts their effectiveness or throughput. Recognising this hurdle, SteriCUBE wholeheartedly supports sterile processing departments. SteriCUBE representatives work tirelessly to make the sterilization department’s job easier and act as advocates within a facility whilst expanding the adoption of the SteriCUBE. SteriCUBE Delivers More Efficient “OR Turnover” Despite the obstacles, SteriCUBE is seeing outstanding growth within the market. “Fortunately, our SteriCUBEs are a significant breakthrough,” said Cara. “They truly bring measurable efficiency to facilities. This is most commonly seen with a metric called OR turnover, which is the amount of time it takes to clean and reset an operating room after surgery. I met with a facility that was routinely having to stay until 7pm because it took so long to turnover its operating rooms. After implementing SteriCUBEs, staff went home at 3pm. They were ecstatic.” Looking ahead, SteriCUBE will continue to enhance surgery across the country, working closely with clients to inject efficiency into the operating room. The company has made significant strides in its mission to reshape the process of surgical instrument processing, becoming a key player in the world of sterilization. It is for this reason that we at Global Health & Pharma are delighted to recognise SteriCUBE as the USA’s Breakthrough Sterilization Technology of the Year 2026. Visit the SteriCUBE website https:// www.thestericube.com/ to learn more. Contact: Cara Bethell Company: SteriCUBE® Web Address: www.thestericube.com Breakthrough Sterilization Technology of the Year 2026 – USA & Best Clinical Implementation Team 2026 – USA SteriCUBE®
ghpnews.digitalRkJQdWJsaXNoZXIy MTUyMDQwMA==